hematology

Hiddo Heerspink, PharmD, PhDCredit: George Institute for Global Health Semaglutide Shows Promise in Managing Chronic Kidney Disease Without Diabetes A recent clinical trial suggests semaglutide (Ozempic) may hold significant potential …

Will Herrington, MA, MBBS, MD, FRCP, FERA Credit: Oxford University Empagliflozin Continues to Protect Kidney Health After Trial Completion New data from the EMPA-KIDNEY trial presented at ASN Kidney Week …

Jennifer Yi-Chun-Lai Yee, MD, PhD, MPHCredit: Michigan Medicine Sparsentan Shows Promise for Patients with Genetic Focal Segmental Glomerulosclerosis (gFSGS) A recent analysis of the DUPLEX trial, the largest clinical trial …

Intellia Therapeutics’ Nex-Z Shows Promise for Treating ATTR-CM Intellia Therapeutics is making waves in the fight against ATTR amyloidosis with cardiomyopathy (ATTR-CM) with its groundbreaking gene editing therapy, nex-z (formerly …